We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

Nasdaq:ABUS

Arbutus Biopharma Corporation (ABUS)

Nasdaq • ABUS • CA03879J1003

3.88Last close

Market Closed

Trading Signals

ORTEX Data Highlights

As of Oct 27, 2026, ORTEX estimated 15.8% of free float sold short, 4.8 days to cover, cost to borrow 0.82%. Sign up for live short interest data.

Market Cap

595m USD | # 5763 in US

Volume

5.04m shares | 23.22m USD

Shares Outstanding

197.85m

Free Float Shares

76.13% | 150.62m

DB:I9DN|

LSE:0SGC

News

ABUS key data

Arbutus Biopharma Corporation (Nasdaq: ABUS) has a market capitalization of $594.78M. Last close $3.88 (as of 2026-11-12); 52-week range $3.50 to $5.45. ORTEX data as of 2026-10-27: short interest was 15.82% of free float, 4.8 days to cover and the average cost to borrow was 0.82%. Sign up for live short interest data.

ABUS news on ORTEX News
ORTEX News
ORTEX public data
ORTEX Charts
ORTEX API

© 2026 ORTEX Technologies Ltd.